The United States has quietly pulled the plug on a $400 million HIV treatment programme in South Africa, leaving thousands of patients in limbo and exposing a cruel vacuum in global health governance. Sources close to the South African Department of Health confirm that the US President’s Emergency Plan for AIDS Relief (PEPFAR) has declined to renew its flagship grant for the province of KwaZulu-Natal, the epicentre of the country’s epidemic. The decision, buried in a routine State Department briefing last week, came without warning or transition plan, according to an internal memo obtained by this paper.
South Africa accounts for nearly one-fifth of the world’s HIV cases. The terminated programme served 1.2 million patients on antiretroviral therapy and supported 3,000 community health workers. Now, those workers have been issued layoff notices, and drug supplies are expected to run out within six weeks. “This is not a funding gap. It is a death sentence for the most vulnerable,” said a programme director who spoke on condition of anonymity for fear of reprisal.
The health minister of KwaZulu-Natal, Dr Nomafrench Mbombo, has publicly appealed for emergency assistance from the Commonwealth. “Britain must step up. The Commonwealth has the capacity, the expertise, and the moral duty to fill this breach,” she told reporters in Durban yesterday. Her plea has found resonance in Westminster. A cross-party group of MPs has drafted an early day motion calling on the Foreign Office to restore “Commonwealth health leadership” by pledging £300 million over three years. The motion, backed by 47 MPs, argues that the UK’s global health influence has waned since the closure of the Department for International Development.
But the government is cautious. The Treasury is already grappling with inflation and a strained NHS. A spokesperson for the Foreign, Commonwealth and Development Office said: “We are reviewing the situation in South Africa and will consider all options within our existing aid budget.” That budget, however, has been slashed from 0.7% to 0.5% of GNI, leaving little room for new commitments.
The withdrawal is part of a broader pattern. Under the Trump administration, US global health funding has been systematically cut. Last year, Washington ended support for 50 health facilities in Uganda. Now South Africa. The message is clear: America is outsourcing its responsibilities, and the casualties will be counted in lives lost.
Britain has a historic role in the fight against HIV. It was a UK-led consortium that first demonstrated the effectiveness of antiretroviral therapy in sub-Saharan Africa. Sir Michael Marmot, the renowned epidemiologist, told me: “The UK has always been a beacon. If we walk away now, we are complicit in a preventable catastrophe.”
The clock is ticking. The next Commonwealth Health Ministers meeting is in June, but South Africa cannot wait that long. The government has already diverted resources from other programmes to keep clinics open, but officials admit it is a stopgap. “We are robbing Peter to pay Paul,” said one official. “And Paul is going to die anyway.”
This is not a story about charity. It is about accountability. The money exists. The know-how exists. What is missing is political will. If Britain does not act, the Commonwealth will become a relic of a bygone era, and the HIV epidemic will surge once more. The ghost of that failure will haunt London’s corridors of power for decades.
